𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗜𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴: 𝗖𝘂𝗿𝗿𝗲𝗻𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗮𝗻𝗱 𝗙𝘂𝘁𝘂𝗿𝗲 𝗣𝗿𝗼𝘀𝗽𝗲𝗰𝘁𝘀

••
Pharma MES
2023 - Berlin
Artificial Intelligence in
Pharmaceutical Manufacturing:
Current Insights and Future
Prospects
Hernan Vilas
Thomas Halfmann
v1.1
Livinginthe
AIHype
• 350 billion words
• 175+ billion parameters
• 100+ million active users
• China now has at least
130 LLMs, accounting for
40% of the global total
and just behind the
United States' 50% share
(Source: Reuters)
• 21. Sep: Microsoft Copilot
announced
https://blogs.microsoft.com/blog/2023/09/21/announc
ing-microsoft-copilot-your-everyday-ai-companion/
2
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
GartnerDataand
AnalyticsHype
Generative AI is at the peak
of inflated expectations
3
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
Hype Cycle for Artificial Intelligence, 2023
Published 19 July 2023 (Gartner, Inc)
https://www.gartner.com/en/documents/4543699
The Reality of AI
4
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
Training data with
input/features x and
label/outputs y
corresponding to
each input. i.e:
images of cats and
dogs
Only input/features x, but
not corresponding
labels/outputs y. i.e: cluster
data that’s similar.
Seek to discover structure
in data
Might have a subset of data with
only inputs x and known
label/outputs y.
the machine learning task might
involve, searching the space, to find
some optimum. Reinforcement
learning: Alpha-Go example
There is a very large variety of machine learning methods and
algorithms, and a major challenge for implementing AI products, is
to be aware of this range of options and methods, and to match the
problem at hand, with the appropriate method.
Parametric
Non-Parametric
Parametric models are what we're most used
to, for most engineering and scientific
experiences. For example, in fitting a line or
curve, to some x data.
How models
learn from data
Model complexity depends on training
samples. i.e: decision trees, random forest,
SVM
Discriminative Given an input x, predict the probability of an
output y. Neural Networks. Deep,
Convolutional, Recurrent and Transformers
Generative Seek to model the joint probability of x and y, or
in some cases, the reverse probability. Given an
output y, what is the probability that different x
values are associated with that y?. GANs:
forward/reverse predictions. (deep-fakes)
Supervised
Learning
Unsupervised
Learning
Semi-
supervised
Learning
Finding a Way Forward
• Improve Human Performance:
AI can generate “super-human”
by augmenting our capabilities
• Science based AI will ensure
adoption in a regulated
environment like pharma.
• Democratize AI: Bring the user
friendliness of a chat bot into
the game to engage operators
and end users. LLMs can be
made available even for a small
company.
5
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
AIinDrugManufacturing–
TheRegulator’sView
FDA Discussion Paper
• FDA has recognized and embraced the potential of advanced
manufacturing and works collaboratively with companies to
support the use of advanced manufacturing
• FDA understands that AI may play a significant role in monitoring
and controlling advanced manufacturing processes
• FDA is asking the industry for feedback to be used for future policy
development
• Questions asked by FDA:
1. What types of AI applications do you envision …?
2. … aspects of the current regulatory framework …that should be considered by
FDA?
3. Would guidance in the area of AI in drug manufacturing be beneficial?
4. What are the necessary elements … to implement AI-based models in CGMP…?
5. What are common practices for validating and maintaining self-learning AI
models …?
6. What are the necessary mechanisms for managing the data used to generate AI
models in pharmaceutical manufacturing?
7. Are there other aspects …?
8. Are there aspects … not covered in this document that FDA should consider?
6
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
https://www.fda.gov/media/165743/download?attachment
AIapplicationsin
pharmaceutical
manufacturing
7
Process monitoring, fault
detection, anomalies and
trend monitoring
Predictive Maintenance,
calibration, validation
Advanced process controls -
Prediction of product
performance and quality.
PAT & Raman on AI models
Batch Release, process
deviation detection and
correction.
AI supported classification
of deviations in QMS
Self documenting CQV
reports for new equipment,
to significantly reduce the
time it takes to deploy new
machinery using generative
AI
Documentation preparation:
Master Batch Records
(MBRs) or population and
data analysis of the Product
Quality Annual Review
AI Co-pilot
SME / operator / expert
support: ‘error free
workflow’
Task automation
Digital Tech Transfer.
Process Design and Scale up
with AI-powered Digital
Twins. Virtual
Commissioning
AI Machine Learning Generative AI
https://www.biophorum.com/download/industry-feedback-on-artificial-intelligence-in-drug-manufacturing-fda-discussion-paper/
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
Challenges with AI-powered Solutions in Manufacturing
• Trust - Operators often distrust systems reliant on historical data during novel events. Building
confidence in AI requires change management.
à Change Management needed to ease the adoption of chatbot / auto-pilot mode for shop floor
operations.
• Bias remediation - Lifecycle management, responsible AI practices, audits and continuous
monitoring is needed to avoid any class specific bias (during training, deployment, algorithmic bias,
etc.)
• Explainability - Ability to explain in understandable terms how and why an AI model makes a certain
prediction or decision.
• Regulators require transparency into model logic and predictions.
• Complex AI models like deep neural networks are inherently black boxes.
• Connected Plant - Data Availability - Collecting large,
high-quality, labelled datasets required to train robust AI models
can be difficult due to proprietary concerns and siloed data.
à AI Hierarchy of Needs
8
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
https://hackernoon.com/the-ai-hierarchy-of-needs-18f111fcc007
Challenges with AI-powered Solutions in Manufacturing
• Validation - Extensive validation is required to prove GMP compliance.
Traditional statistical validation methods may not apply well to
AI systems.
• Regulatory Uncertainty - Lack of clear regulatory guidelines for
evaluating and certifying AI software creates ambiguity and risk for
manufacturers considering adoption.
à Leverage “Artificial Intelligence/Machine Learning (AI/ML)-Based
Software as a Medical Device (SaMD) Action Plan”
• Data privacy (IP protection, cybersecurity). Mainly with the extended
use of Generative AI platforms.
9
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
https://www.fda.gov/media/145022/download
ARealityCheck
Survey 2023:
AI in Biopharmaceutical
Manufacturing
-
How do MES solution
providers adopt AI today?
10
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
Survey: AI in Manufacturing
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Is your company investing in developing AI as part of
your products?
Have you released any AI products or features?
Are the AI features fully integrated into the core
software?
11
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
Which areas of biopharmaceutical manufacturing will see the
most adoption in the next 3 years?
0% 10% 20% 30% 40% 50% 60% 70%
Advanced process control
Process monitoring, fault detection, anomalies and
trend monitoring
Expert support: ‘error free workflow’
Predictive maintenance
Production scheduling
Quality/defect detection
Yield optimization
Other (please specify)
12
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
What are the biggest potential benefits of AI in
biopharmaceutical manufacturing?
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Automating complex tasks
Uncovering hidden insights
Increasing production efficiency
Reducing costs
Other (please specify)
13
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
How receptive are your biopharmaceutical clients to adopting
AI-based manufacturing software solutions?
0% 10% 20% 30% 40% 50% 60%
Very receptive
Somewhat receptive
Not very receptive
Not sure
14
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
How important are the following factors in your clients'
decisions to adopt AI? (5 being extremely important)
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
Demonstrated return on investment
Regulatory compliance
Data security
Algorithm transparency (explainability)
Ease of integration with existing systems
15
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
Survey: AI in Manufacturing (Observations)
16
1) MES solution providers look beyond the traditional AI solutions and benefits, e.g.
• Adaptive process control
• ChatGPT like product to support implementation partners, power users, operators, …
• Generative AI guided MBR design (Co-Pilot)
• Conversion of paper(-on-glass) MBRs into MES ready-to-use recipes
• Automatic text translation
• Plain text queries on manufacturing data
• …
2) Access to (the right) data is essential – the connected factory is a pre-requisite
3) Maturity and readiness is key: process, people and technology must be ready
and mature to adopt Generative AI
• Regulatory requirements must be fully understood and addressed
• An assessment based upon the Digital plant maturity model (DPMM) helps to understand and
create the roadmap for digital transformation and AI
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
17
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
2024Survey
AI in Biopharmaceutical
Manufacturing
• Maturity?
• Status of Adoption?
• Benefits of AI?
• Challenges, concerns &
risks?
• … Target audience:
• Industry
• Solution Providers
• Consulting & Services Companies
18
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
Conclusions …
• AI-powered solutions have reached the right level of maturity to support
decisions. In many cases, they are the only option to analyze and
evaluate highly complex data sets that are impossible for a human
• Data Strategy: capturing, integration and management of data assets will
ensure a consistent outcome of the AI models (garbage in / out principle)
• MES, Automation, OT Architecture are the foundations of the Factory of
the Future, powered by data, AI models and advanced process controls
to reach the vision of a continuous, fully automated and integrated
lights-off manufacturing
• Start now: understand where you are today, what is your digital maturity
(DPMM assessment) and where you want to go (the Roadmap to the
Factory of the Future)
We love to engage with you and stay connected …
Hernan Vilas Thomas Halfmann
19
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
20
Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
Hernan Thomas
1 sur 20

Recommandé

Smart manufacturing industry 4.0 par
Smart manufacturing industry 4.0Smart manufacturing industry 4.0
Smart manufacturing industry 4.0kailaash arumugam
365 vues•17 diapositives
Conversational AI and Chatbot Integrations par
Conversational AI and Chatbot IntegrationsConversational AI and Chatbot Integrations
Conversational AI and Chatbot IntegrationsCristina Vidu
443 vues•24 diapositives
AI Solutions in Manufacturing par
AI Solutions in ManufacturingAI Solutions in Manufacturing
AI Solutions in ManufacturingSri Ambati
3.7K vues•16 diapositives
Everything about Internet of Things par
Everything about Internet of ThingsEverything about Internet of Things
Everything about Internet of ThingsMuhammad Hassan Nasr
6.2K vues•112 diapositives
AI for Manufacturing (Machine Vision, Edge AI, Federated Learning) par
AI for Manufacturing (Machine Vision, Edge AI, Federated Learning)AI for Manufacturing (Machine Vision, Edge AI, Federated Learning)
AI for Manufacturing (Machine Vision, Edge AI, Federated Learning)byteLAKE
729 vues•35 diapositives
The Insurance AI Imperative par
The Insurance AI ImperativeThe Insurance AI Imperative
The Insurance AI ImperativeCognizant
436 vues•20 diapositives

Contenu connexe

Tendances

Blockchain In Industry 4.0 par
Blockchain In Industry 4.0Blockchain In Industry 4.0
Blockchain In Industry 4.0Stacey Roberts
426 vues•25 diapositives
COVID-19 Rapid Response Checklist for Nonprofits par
COVID-19 Rapid Response Checklist for NonprofitsCOVID-19 Rapid Response Checklist for Nonprofits
COVID-19 Rapid Response Checklist for NonprofitsBoston Consulting Group
2.9K vues•13 diapositives
The Top 10 Artificial Intelligence Trends Everyone Should Be Watching In 2020 par
The Top 10 Artificial Intelligence Trends Everyone Should Be Watching In 2020The Top 10 Artificial Intelligence Trends Everyone Should Be Watching In 2020
The Top 10 Artificial Intelligence Trends Everyone Should Be Watching In 2020Bernard Marr
7.3K vues•17 diapositives
How to quickly make flashcards par
How to quickly make flashcardsHow to quickly make flashcards
How to quickly make flashcardsjollibee
2.9K vues•10 diapositives
Healthcare in Digital Age par
Healthcare in Digital Age Healthcare in Digital Age
Healthcare in Digital Age ict moph
546 vues•27 diapositives
Applying AI to software engineering problems: Do not forget the human! par
Applying AI to software engineering problems: Do not forget the human!Applying AI to software engineering problems: Do not forget the human!
Applying AI to software engineering problems: Do not forget the human!University of Córdoba
192 vues•16 diapositives

Tendances(20)

Blockchain In Industry 4.0 par Stacey Roberts
Blockchain In Industry 4.0Blockchain In Industry 4.0
Blockchain In Industry 4.0
Stacey Roberts•426 vues
The Top 10 Artificial Intelligence Trends Everyone Should Be Watching In 2020 par Bernard Marr
The Top 10 Artificial Intelligence Trends Everyone Should Be Watching In 2020The Top 10 Artificial Intelligence Trends Everyone Should Be Watching In 2020
The Top 10 Artificial Intelligence Trends Everyone Should Be Watching In 2020
Bernard Marr•7.3K vues
How to quickly make flashcards par jollibee
How to quickly make flashcardsHow to quickly make flashcards
How to quickly make flashcards
jollibee•2.9K vues
Healthcare in Digital Age par ict moph
Healthcare in Digital Age Healthcare in Digital Age
Healthcare in Digital Age
ict moph•546 vues
Applying AI to software engineering problems: Do not forget the human! par University of Córdoba
Applying AI to software engineering problems: Do not forget the human!Applying AI to software engineering problems: Do not forget the human!
Applying AI to software engineering problems: Do not forget the human!
Gen AI Cognizant & AWS event presentation_12 Oct.pdf par PhilipBasford
Gen AI Cognizant & AWS event presentation_12 Oct.pdfGen AI Cognizant & AWS event presentation_12 Oct.pdf
Gen AI Cognizant & AWS event presentation_12 Oct.pdf
PhilipBasford•115 vues
How Chatbots Can Transform Your Business par Techedge Group
How Chatbots Can Transform Your BusinessHow Chatbots Can Transform Your Business
How Chatbots Can Transform Your Business
Techedge Group•959 vues
Accenture Digital Health Technology Vision 2018 par accenture
Accenture Digital Health Technology Vision 2018Accenture Digital Health Technology Vision 2018
Accenture Digital Health Technology Vision 2018
accenture•23.4K vues
The future of machine learning platform par GAVS Technologies
The future of machine learning platformThe future of machine learning platform
The future of machine learning platform
GAVS Technologies•355 vues
On The Way To Smart Factory par Dell World
On The Way To Smart FactoryOn The Way To Smart Factory
On The Way To Smart Factory
Dell World•6.4K vues
AI and the Professions of the Future par Svetlin Nakov
AI and the Professions of the FutureAI and the Professions of the Future
AI and the Professions of the Future
Svetlin Nakov•997 vues
Smart manufacturing – Industrial Automation Solutions par Unmesh Ballal
Smart manufacturing – Industrial Automation SolutionsSmart manufacturing – Industrial Automation Solutions
Smart manufacturing – Industrial Automation Solutions
Unmesh Ballal•2.5K vues
Meetup #3 - Cyber-physical view of the Internet of Everything par Francesco Rago
Meetup #3 - Cyber-physical view of the Internet of EverythingMeetup #3 - Cyber-physical view of the Internet of Everything
Meetup #3 - Cyber-physical view of the Internet of Everything
Francesco Rago•1.1K vues
LLM presentation final par Ruth Griffin
LLM presentation finalLLM presentation final
LLM presentation final
Ruth Griffin•1.2K vues
Maximizing Enterprise AI Investments | Accenture par accenture
Maximizing Enterprise AI Investments | AccentureMaximizing Enterprise AI Investments | Accenture
Maximizing Enterprise AI Investments | Accenture
accenture•15.3K vues

Similaire à 𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗜𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴: 𝗖𝘂𝗿𝗿𝗲𝗻𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗮𝗻𝗱 𝗙𝘂𝘁𝘂𝗿𝗲 𝗣𝗿𝗼𝘀𝗽𝗲𝗰𝘁𝘀

artificial intelligence in Pharmacy field.pptx par
artificial intelligence in Pharmacy field.pptxartificial intelligence in Pharmacy field.pptx
artificial intelligence in Pharmacy field.pptxpriyranjan8
725 vues•19 diapositives
AI & Analytics Predictions of 2022. Infographic par
AI & Analytics Predictions of 2022. InfographicAI & Analytics Predictions of 2022. Infographic
AI & Analytics Predictions of 2022. InfographicInData Labs
62 vues•28 diapositives
The State of Global AI Adoption in 2023 par
The State of Global AI Adoption in 2023The State of Global AI Adoption in 2023
The State of Global AI Adoption in 2023InData Labs
115 vues•19 diapositives
UTILITY OF AI par
UTILITY OF AIUTILITY OF AI
UTILITY OF AIAndre Muscat
335 vues•32 diapositives
CB-Insights_Big-Tech-In-Pharma.pdf par
CB-Insights_Big-Tech-In-Pharma.pdfCB-Insights_Big-Tech-In-Pharma.pdf
CB-Insights_Big-Tech-In-Pharma.pdfshekhar suman
44 vues•60 diapositives
The FDA’s Medical Device Action Plan for Artificial Intelligence and Machine ... par
The FDA’s Medical Device Action Plan for Artificial Intelligence and Machine ...The FDA’s Medical Device Action Plan for Artificial Intelligence and Machine ...
The FDA’s Medical Device Action Plan for Artificial Intelligence and Machine ...EMMAIntl
20 vues•2 diapositives

Similaire à 𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗜𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴: 𝗖𝘂𝗿𝗿𝗲𝗻𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗮𝗻𝗱 𝗙𝘂𝘁𝘂𝗿𝗲 𝗣𝗿𝗼𝘀𝗽𝗲𝗰𝘁𝘀(20)

artificial intelligence in Pharmacy field.pptx par priyranjan8
artificial intelligence in Pharmacy field.pptxartificial intelligence in Pharmacy field.pptx
artificial intelligence in Pharmacy field.pptx
priyranjan8•725 vues
AI & Analytics Predictions of 2022. Infographic par InData Labs
AI & Analytics Predictions of 2022. InfographicAI & Analytics Predictions of 2022. Infographic
AI & Analytics Predictions of 2022. Infographic
InData Labs•62 vues
The State of Global AI Adoption in 2023 par InData Labs
The State of Global AI Adoption in 2023The State of Global AI Adoption in 2023
The State of Global AI Adoption in 2023
InData Labs•115 vues
CB-Insights_Big-Tech-In-Pharma.pdf par shekhar suman
CB-Insights_Big-Tech-In-Pharma.pdfCB-Insights_Big-Tech-In-Pharma.pdf
CB-Insights_Big-Tech-In-Pharma.pdf
shekhar suman•44 vues
The FDA’s Medical Device Action Plan for Artificial Intelligence and Machine ... par EMMAIntl
The FDA’s Medical Device Action Plan for Artificial Intelligence and Machine ...The FDA’s Medical Device Action Plan for Artificial Intelligence and Machine ...
The FDA’s Medical Device Action Plan for Artificial Intelligence and Machine ...
EMMAIntl•20 vues
Product data management market par HarshalBamble
Product data management marketProduct data management market
Product data management market
HarshalBamble•51 vues
Ibm's global ai adoption index 2021 executive summary par Emisor Digital
Ibm's global ai adoption index 2021 executive summaryIbm's global ai adoption index 2021 executive summary
Ibm's global ai adoption index 2021 executive summary
Emisor Digital•143 vues
A Proposed Framework for Regulating AI Based Applications in SaMD par EMMAIntl
A Proposed Framework for Regulating AI Based Applications in SaMDA Proposed Framework for Regulating AI Based Applications in SaMD
A Proposed Framework for Regulating AI Based Applications in SaMD
EMMAIntl•32 vues
Quality Systems and Good Machine Learning Practices par EMMAIntl
Quality Systems and Good Machine Learning PracticesQuality Systems and Good Machine Learning Practices
Quality Systems and Good Machine Learning Practices
EMMAIntl•27 vues
How Artificial Intelligence is revolutionizing Industry 4.0.pdf par Factory Worx
How Artificial Intelligence is revolutionizing Industry 4.0.pdfHow Artificial Intelligence is revolutionizing Industry 4.0.pdf
How Artificial Intelligence is revolutionizing Industry 4.0.pdf
Factory Worx•54 vues
IRJET- Impact of AI in Manufacturing Industries par IRJET Journal
IRJET- Impact of AI in Manufacturing IndustriesIRJET- Impact of AI in Manufacturing Industries
IRJET- Impact of AI in Manufacturing Industries
IRJET Journal•63 vues
Artificial intelligence in manufacturing par Ashutosh Sable
Artificial intelligence in manufacturingArtificial intelligence in manufacturing
Artificial intelligence in manufacturing
Ashutosh Sable•95 vues
Smart factory market par ameliasimon0
Smart factory marketSmart factory market
Smart factory market
ameliasimon0•41 vues
Warranty management system market par DineshBhol
Warranty management system marketWarranty management system market
Warranty management system market
DineshBhol•46 vues
Welcome to the Cognitive Supply Chain par Cor Ranzijn
Welcome to the Cognitive Supply ChainWelcome to the Cognitive Supply Chain
Welcome to the Cognitive Supply Chain
Cor Ranzijn•438 vues
Advanced Manufacturing – Solutions That Are Transforming the Industry par MRPeasy
Advanced Manufacturing – Solutions That Are Transforming the IndustryAdvanced Manufacturing – Solutions That Are Transforming the Industry
Advanced Manufacturing – Solutions That Are Transforming the Industry
MRPeasy•46 vues
Human Machine Interface Market PPT 2021-26 | Enhancing Huge Growth and Latest... par IMARC Group
Human Machine Interface Market PPT 2021-26 | Enhancing Huge Growth and Latest...Human Machine Interface Market PPT 2021-26 | Enhancing Huge Growth and Latest...
Human Machine Interface Market PPT 2021-26 | Enhancing Huge Growth and Latest...
IMARC Group•27 vues

Dernier

Consolidated Career Maps (1).pdf par
Consolidated Career Maps (1).pdfConsolidated Career Maps (1).pdf
Consolidated Career Maps (1).pdfvishankchauhan1
15 vues•561 diapositives
UNIT XIII Cognitive Process.pptx par
UNIT XIII Cognitive Process.pptxUNIT XIII Cognitive Process.pptx
UNIT XIII Cognitive Process.pptxProf. (Dr.) Rahul Sharma
96 vues•62 diapositives
Deafening Silence par
Deafening SilenceDeafening Silence
Deafening SilenceSarah Carpino
42 vues•14 diapositives
Alternatives to Leniency Programmes – SERBIA – December 2023 OECD discussion par
Alternatives to Leniency Programmes – SERBIA – December 2023 OECD discussionAlternatives to Leniency Programmes – SERBIA – December 2023 OECD discussion
Alternatives to Leniency Programmes – SERBIA – December 2023 OECD discussionOECD Directorate for Financial and Enterprise Affairs
66 vues•5 diapositives
Maximiliano Roa - eRetail Week Blended [Professional] Experience 2023 par
Maximiliano Roa - eRetail Week Blended [Professional] Experience 2023Maximiliano Roa - eRetail Week Blended [Professional] Experience 2023
Maximiliano Roa - eRetail Week Blended [Professional] Experience 2023eCommerce Institute
7 vues•14 diapositives
Out-of-Market Efficiencies in Competition Enforcement – ROSENBOOM – December ... par
Out-of-Market Efficiencies in Competition Enforcement – ROSENBOOM – December ...Out-of-Market Efficiencies in Competition Enforcement – ROSENBOOM – December ...
Out-of-Market Efficiencies in Competition Enforcement – ROSENBOOM – December ...OECD Directorate for Financial and Enterprise Affairs
74 vues•10 diapositives

Dernier(20)

Consolidated Career Maps (1).pdf par vishankchauhan1
Consolidated Career Maps (1).pdfConsolidated Career Maps (1).pdf
Consolidated Career Maps (1).pdf
vishankchauhan1•15 vues
Maximiliano Roa - eRetail Week Blended [Professional] Experience 2023 par eCommerce Institute
Maximiliano Roa - eRetail Week Blended [Professional] Experience 2023Maximiliano Roa - eRetail Week Blended [Professional] Experience 2023
Maximiliano Roa - eRetail Week Blended [Professional] Experience 2023
Learning from Disaster - How a positive safety approach saves lives_MYOSH Web... par kristinashields1
Learning from Disaster - How a positive safety approach saves lives_MYOSH Web...Learning from Disaster - How a positive safety approach saves lives_MYOSH Web...
Learning from Disaster - How a positive safety approach saves lives_MYOSH Web...
kristinashields1•39 vues
CIS1- Final-Project- COPY-Presentation-JinHuan Chen, Tammy Ling, JingCheng Zh... par tmmling
CIS1- Final-Project- COPY-Presentation-JinHuan Chen, Tammy Ling, JingCheng Zh...CIS1- Final-Project- COPY-Presentation-JinHuan Chen, Tammy Ling, JingCheng Zh...
CIS1- Final-Project- COPY-Presentation-JinHuan Chen, Tammy Ling, JingCheng Zh...
tmmling•14 vues
limited green areas in albateen.pdf par metha4399
limited green areas in albateen.pdflimited green areas in albateen.pdf
limited green areas in albateen.pdf
metha4399•6 vues
RTC2023_Boost-App-Integration-with-AI_Kim.pdf par hossenkamal2
RTC2023_Boost-App-Integration-with-AI_Kim.pdfRTC2023_Boost-App-Integration-with-AI_Kim.pdf
RTC2023_Boost-App-Integration-with-AI_Kim.pdf
hossenkamal2•8 vues

𝗔𝗿𝘁𝗶𝗳𝗶𝗰𝗶𝗮𝗹 𝗜𝗻𝘁𝗲𝗹𝗹𝗶𝗴𝗲𝗻𝗰𝗲 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴: 𝗖𝘂𝗿𝗿𝗲𝗻𝘁 𝗜𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗮𝗻𝗱 𝗙𝘂𝘁𝘂𝗿𝗲 𝗣𝗿𝗼𝘀𝗽𝗲𝗰𝘁𝘀

  • 1. Pharma MES 2023 - Berlin Artificial Intelligence in Pharmaceutical Manufacturing: Current Insights and Future Prospects Hernan Vilas Thomas Halfmann v1.1
  • 2. Livinginthe AIHype • 350 billion words • 175+ billion parameters • 100+ million active users • China now has at least 130 LLMs, accounting for 40% of the global total and just behind the United States' 50% share (Source: Reuters) • 21. Sep: Microsoft Copilot announced https://blogs.microsoft.com/blog/2023/09/21/announc ing-microsoft-copilot-your-everyday-ai-companion/ 2 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
  • 3. GartnerDataand AnalyticsHype Generative AI is at the peak of inflated expectations 3 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann) Hype Cycle for Artificial Intelligence, 2023 Published 19 July 2023 (Gartner, Inc) https://www.gartner.com/en/documents/4543699
  • 4. The Reality of AI 4 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann) Training data with input/features x and label/outputs y corresponding to each input. i.e: images of cats and dogs Only input/features x, but not corresponding labels/outputs y. i.e: cluster data that’s similar. Seek to discover structure in data Might have a subset of data with only inputs x and known label/outputs y. the machine learning task might involve, searching the space, to find some optimum. Reinforcement learning: Alpha-Go example There is a very large variety of machine learning methods and algorithms, and a major challenge for implementing AI products, is to be aware of this range of options and methods, and to match the problem at hand, with the appropriate method. Parametric Non-Parametric Parametric models are what we're most used to, for most engineering and scientific experiences. For example, in fitting a line or curve, to some x data. How models learn from data Model complexity depends on training samples. i.e: decision trees, random forest, SVM Discriminative Given an input x, predict the probability of an output y. Neural Networks. Deep, Convolutional, Recurrent and Transformers Generative Seek to model the joint probability of x and y, or in some cases, the reverse probability. Given an output y, what is the probability that different x values are associated with that y?. GANs: forward/reverse predictions. (deep-fakes) Supervised Learning Unsupervised Learning Semi- supervised Learning
  • 5. Finding a Way Forward • Improve Human Performance: AI can generate “super-human” by augmenting our capabilities • Science based AI will ensure adoption in a regulated environment like pharma. • Democratize AI: Bring the user friendliness of a chat bot into the game to engage operators and end users. LLMs can be made available even for a small company. 5 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
  • 6. AIinDrugManufacturing– TheRegulator’sView FDA Discussion Paper • FDA has recognized and embraced the potential of advanced manufacturing and works collaboratively with companies to support the use of advanced manufacturing • FDA understands that AI may play a significant role in monitoring and controlling advanced manufacturing processes • FDA is asking the industry for feedback to be used for future policy development • Questions asked by FDA: 1. What types of AI applications do you envision …? 2. … aspects of the current regulatory framework …that should be considered by FDA? 3. Would guidance in the area of AI in drug manufacturing be beneficial? 4. What are the necessary elements … to implement AI-based models in CGMP…? 5. What are common practices for validating and maintaining self-learning AI models …? 6. What are the necessary mechanisms for managing the data used to generate AI models in pharmaceutical manufacturing? 7. Are there other aspects …? 8. Are there aspects … not covered in this document that FDA should consider? 6 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann) https://www.fda.gov/media/165743/download?attachment
  • 7. AIapplicationsin pharmaceutical manufacturing 7 Process monitoring, fault detection, anomalies and trend monitoring Predictive Maintenance, calibration, validation Advanced process controls - Prediction of product performance and quality. PAT & Raman on AI models Batch Release, process deviation detection and correction. AI supported classification of deviations in QMS Self documenting CQV reports for new equipment, to significantly reduce the time it takes to deploy new machinery using generative AI Documentation preparation: Master Batch Records (MBRs) or population and data analysis of the Product Quality Annual Review AI Co-pilot SME / operator / expert support: ‘error free workflow’ Task automation Digital Tech Transfer. Process Design and Scale up with AI-powered Digital Twins. Virtual Commissioning AI Machine Learning Generative AI https://www.biophorum.com/download/industry-feedback-on-artificial-intelligence-in-drug-manufacturing-fda-discussion-paper/ Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
  • 8. Challenges with AI-powered Solutions in Manufacturing • Trust - Operators often distrust systems reliant on historical data during novel events. Building confidence in AI requires change management. à Change Management needed to ease the adoption of chatbot / auto-pilot mode for shop floor operations. • Bias remediation - Lifecycle management, responsible AI practices, audits and continuous monitoring is needed to avoid any class specific bias (during training, deployment, algorithmic bias, etc.) • Explainability - Ability to explain in understandable terms how and why an AI model makes a certain prediction or decision. • Regulators require transparency into model logic and predictions. • Complex AI models like deep neural networks are inherently black boxes. • Connected Plant - Data Availability - Collecting large, high-quality, labelled datasets required to train robust AI models can be difficult due to proprietary concerns and siloed data. à AI Hierarchy of Needs 8 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann) https://hackernoon.com/the-ai-hierarchy-of-needs-18f111fcc007
  • 9. Challenges with AI-powered Solutions in Manufacturing • Validation - Extensive validation is required to prove GMP compliance. Traditional statistical validation methods may not apply well to AI systems. • Regulatory Uncertainty - Lack of clear regulatory guidelines for evaluating and certifying AI software creates ambiguity and risk for manufacturers considering adoption. à Leverage “Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan” • Data privacy (IP protection, cybersecurity). Mainly with the extended use of Generative AI platforms. 9 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann) https://www.fda.gov/media/145022/download
  • 10. ARealityCheck Survey 2023: AI in Biopharmaceutical Manufacturing - How do MES solution providers adopt AI today? 10 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
  • 11. Survey: AI in Manufacturing 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Is your company investing in developing AI as part of your products? Have you released any AI products or features? Are the AI features fully integrated into the core software? 11 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
  • 12. Which areas of biopharmaceutical manufacturing will see the most adoption in the next 3 years? 0% 10% 20% 30% 40% 50% 60% 70% Advanced process control Process monitoring, fault detection, anomalies and trend monitoring Expert support: ‘error free workflow’ Predictive maintenance Production scheduling Quality/defect detection Yield optimization Other (please specify) 12 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
  • 13. What are the biggest potential benefits of AI in biopharmaceutical manufacturing? 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Automating complex tasks Uncovering hidden insights Increasing production efficiency Reducing costs Other (please specify) 13 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
  • 14. How receptive are your biopharmaceutical clients to adopting AI-based manufacturing software solutions? 0% 10% 20% 30% 40% 50% 60% Very receptive Somewhat receptive Not very receptive Not sure 14 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
  • 15. How important are the following factors in your clients' decisions to adopt AI? (5 being extremely important) 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 Demonstrated return on investment Regulatory compliance Data security Algorithm transparency (explainability) Ease of integration with existing systems 15 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
  • 16. Survey: AI in Manufacturing (Observations) 16 1) MES solution providers look beyond the traditional AI solutions and benefits, e.g. • Adaptive process control • ChatGPT like product to support implementation partners, power users, operators, … • Generative AI guided MBR design (Co-Pilot) • Conversion of paper(-on-glass) MBRs into MES ready-to-use recipes • Automatic text translation • Plain text queries on manufacturing data • … 2) Access to (the right) data is essential – the connected factory is a pre-requisite 3) Maturity and readiness is key: process, people and technology must be ready and mature to adopt Generative AI • Regulatory requirements must be fully understood and addressed • An assessment based upon the Digital plant maturity model (DPMM) helps to understand and create the roadmap for digital transformation and AI Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
  • 17. 17 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann) 2024Survey AI in Biopharmaceutical Manufacturing • Maturity? • Status of Adoption? • Benefits of AI? • Challenges, concerns & risks? • … Target audience: • Industry • Solution Providers • Consulting & Services Companies
  • 18. 18 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann) Conclusions … • AI-powered solutions have reached the right level of maturity to support decisions. In many cases, they are the only option to analyze and evaluate highly complex data sets that are impossible for a human • Data Strategy: capturing, integration and management of data assets will ensure a consistent outcome of the AI models (garbage in / out principle) • MES, Automation, OT Architecture are the foundations of the Factory of the Future, powered by data, AI models and advanced process controls to reach the vision of a continuous, fully automated and integrated lights-off manufacturing • Start now: understand where you are today, what is your digital maturity (DPMM assessment) and where you want to go (the Roadmap to the Factory of the Future)
  • 19. We love to engage with you and stay connected … Hernan Vilas Thomas Halfmann 19 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann)
  • 20. 20 Pharma MES 2023 – AI in Pharmaceutical Manufacturing: Current Insights and Future Prospects (Vilas & Halfmann) Hernan Thomas